Aquinox Pharmaceuticals Completes LEADERSHIP Study

Aquinox Pharmaceuticals Completes LEADERSHIP Study

We have recently completed a phase II trial with Aquinox Pharmaceuticals  known as LEADERSHIP Study. The trial investigated the therapeutic potential of AQX-1125 in treating pain in patients with bladder pain syndrome/interstitial cystitis (BPS/IC).

As a technology partner, we have developed pain diaries and voiding diaries to capture voiding frequency and volume, all delivered on a 7 inch tablet. The patients were able to complete the ePROs as they went about their daily routines. The portability of the device and cellular connectivity allowed the patients to take the device anywhere and submit their daily diaries, even while on vacation. We congratulate Aquinox Pharmaceuticals on completing the study and wish them the best in further development of AQX1125.

For more on the LEADERSHIP study and results, please click here.

HealthDiary provides Electronic Data Capture (EDC), Patient Diaries (ePRO) and Patient Registry services to Biopharma and CRO organizations. To learn more about our services, please contact us today.